Predictions
Paul Hartmann AG
Start price
Target price
Perf. (%)
€353.00
30.06.21
30.06.21
€400.00
30.06.22
30.06.22
3.40%
10.07.21
10.07.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Veeva Systems A
Start price
Target price
Perf. (%)
€269.00
29.06.21
29.06.21
€275.00
29.06.22
29.06.22
-29.38%
29.06.22
29.06.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Innovative
Some uniques
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€7.20
25.06.21
25.06.21
-
25.06.22
25.06.22
-26.39%
30.06.21
30.06.21
Could be very worthwhile Investment >20% year
Sartorius AG VZO
Start price
Target price
Perf. (%)
€413.70
18.06.21
18.06.21
€600.00
18.06.22
18.06.22
35.75%
27.09.21
27.09.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
ShockWave Medical Inc
Start price
Target price
Perf. (%)
€159.00
16.06.21
16.06.21
€225.00
16.06.22
16.06.22
-5.66%
16.06.22
16.06.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€488.40
15.06.21
15.06.21
-
15.06.22
15.06.22
-27.06%
21.05.22
21.05.22
EBIT growth >5% per year expected
Very low/no dividend yield expected
CareCloud Inc.
Start price
Target price
Perf. (%)
€7.30
12.06.21
12.06.21
€8.50
12.06.22
12.06.22
-6.16%
10.07.21
10.07.21
Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Hologic Inc.
Start price
Target price
Perf. (%)
€49.93
07.06.21
07.06.21
€55.00
07.06.22
07.06.22
42.14%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€238.80
07.06.21
07.06.21
€250.00
29.04.22
29.04.22
15.03%
30.04.22
30.04.22
Could be worthwhile Investment >10% per year
Diasorin SpA
Start price
Target price
Perf. (%)
€142.25
06.06.21
06.06.21
-
06.06.22
06.06.22
-15.04%
07.06.22
07.06.22
Could be worthwhile Investment >10% per year
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.30
02.06.21
02.06.21
-
02.06.22
02.06.22
9.09%
20.06.21
20.06.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
M1 Kliniken AG
Start price
Target price
Perf. (%)
€10.35
31.05.21
31.05.21
-
31.05.24
31.05.24
40.10%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Teladoc Health Inc
Start price
Target price
Perf. (%)
€128.00
30.05.21
30.05.21
€96.00
30.05.22
30.05.22
-32.52%
20.12.21
20.12.21
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€75.60
26.05.21
26.05.21
€82.00
26.05.22
26.05.22
-36.11%
27.05.22
27.05.22
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€74.55
07.05.21
07.05.21
€60.00
07.05.22
07.05.22
-37.42%
08.05.22
08.05.22
Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€40.55
04.05.21
04.05.21
€55.00
04.05.22
04.05.22
-11.84%
05.05.22
05.05.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Undervalued
Ensign Group Inc.
Start price
Target price
Perf. (%)
€71.50
03.05.21
03.05.21
€78.00
03.05.22
03.05.22
2.80%
04.05.22
04.05.22
Could be worthwhile Investment >10% per year
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€81.20
03.05.21
03.05.21
€75.00
03.05.22
03.05.22
-41.82%
04.05.22
04.05.22
Could be worthwhile Investment >10% per year
Motus GI Holdings Inc.
Start price
Target price
Perf. (%)
€23.00
02.05.21
02.05.21
-
02.05.22
02.05.22
-82.60%
03.05.22
03.05.22
Could be worthwhile Investment >10% per year
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.70
02.05.21
02.05.21
-
02.05.22
02.05.22
1.08%
16.05.21
16.05.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Humana Inc.
Start price
Target price
Perf. (%)
€370.00
01.05.21
01.05.21
-
01.05.22
01.05.22
-5.65%
02.09.21
02.09.21
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
Centene Corp.
Start price
Target price
Perf. (%)
€51.00
01.05.21
01.05.21
€56.00
01.05.22
01.05.22
50.31%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year